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Bovine Coronavirus and Bovine Respiratory Syncytial Virus 
Infections in Dairy Herds, Prospects for Control 
Abstract 
Bovine coronavirus (BCV) and bovine respiratory syncytial virus (BRSV) are 
significant causes of enteric and respiratory disease in cattle throughout the world. 
The aim of this thesis was to gain further knowledge of the epidemiology of these 
infections in Swedish dairy herds.  
Two studies were conducted of the association between BCV/BRSV antibody 
status and health and performance, on herd (79 herds) and individual animal level 
(65 herds). The analyses were carried out using survival, linear regression, and 
logistic regression models. Herds that were antibody-positive to BCV and/or BRSV 
had higher bulk tank milk (BTM) somatic cell count than herds negative to both 
BCV and BRSV. Cows in herds with recent BRSV infection had a lower milk yield 
than cows in BRSV-free herds, and cows in herds with clinical signs of BRSV 
infection had a higher somatic cell count than cows in herds without clinical signs.  
In the third study, the effect of herd-level risk factors on antibody status was 
quantified in 257 herds using logistic regression models and spatial analysis. Large 
herd size, being located in southern Sweden, and not providing boots for visitors 
were found to be associated with antibody positivity to BCV and BRSV, while short 
distance to nearest cattle herd was additionally associated with positivity to BCV. 
Providing boots for visitors likely reflects herds with a high level of biosecurity 
measures. Neither BCV-positive nor BRSV-positive herds were spatially clustered, 
indicating that local spread and airborne transmission are not of great importance.  
The fourth study investigated the long-term dynamics of BCV and BRSV 
infections in 20 herds from each of two southern and two northern areas. There 
was a high prevalence of BCV and BRSV amongst the herds in the southern areas, 
and a lower prevalence in the northern areas; one of the latter was free from BRSV 
at the end of the study. There was also self-clearance of BCV and BRSV, manifesting 
as conversion from antibody positive to negative in pooled milk samples and BTM. 
The results of this thesis suggest that it is possible to develop inexpensive 
strategies for controlling BCV and BSRV infections, based on biosecurity and 
antibody monitoring. Such a control strategy would improve cattle and calf health.  
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”Det går aldrig – och dessutom är det omöjligt” 
Öländsk devis 
 
 
“Who's to say 
What's impossible 
Well they forgot 
This world keeps spinning 
And with each new day 
I can feel a change in everything 
… 
I want to turn the whole thing upside down 
I'll find the things they say just can't be found 
I'll share this love I find with everyone” 
Jack Johnson, Upside down (Curious George 2005) 
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1  Introduction 
Bovine coronavirus (BCV) and bovine respiratory syncytial virus (BRSV) are 
two contagious pathogens affecting beef and dairy cattle worldwide 
(Valarcher & Taylor, 2007; Clark, 1993). Infection with BCV causes 
diarrhoea and various degrees of respiratory tract disease, while BRSV 
infection manifests as respiratory tract disease, fever, and in severe cases 
subcutaneous emphysema and death.  These infections are widespread  in 
Swedish cattle herds, with negative consequences both for animal welfare 
and for the economic situation of the farmer (Elvander, 1996; Tråvén et al., 
1993; Larsson et al., 1991; Jacobsson et al., 1989).  
A common belief among Swedish farmers and veterinarians is that the 
inter-herd spread of BCV and BRSV cannot be controlled. Some even believe 
that regular infection is beneficial, in that it confers immunity on the 
animals. Observations show, however, that there are dairy herds that have 
stayed free from BCV and BRSV infections for many years. To develop 
effective control strategies for BCV and BRSV the epidemiology needs to be 
clarified, including risk factors for transmission and accurate estimates of the 
associated effects on herd health and performance. 
The overall aim of this doctoral research was to gain further knowledge 
of the epidemiology of BCV and BRSV infections in Swedish dairy herds. 
Chapter 2 gives a general background to BCV and BRSV infections in dairy 
herds; chapters 3–6 are devoted to the studies conducted during this 
doctoral work; and chapter 7 summarises areas identified for further 
research. 
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2  Background 
2.1  Beef and dairy cattle in Sweden 
In 2009 there were roughly 1.5 million cattle in Sweden, 360 000 of which 
were dairy cows and 190 000 suckler cows (Swedish Board of Agriculture, 
2010). These dairy cattle were organised into 6020 herds with a mean size 
of 59 cows and a mean milk yield of 9162 kg per cow-year. The 
development of dairy herds in recent decades has been towards fewer but 
larger herds; between 1980 and 2008, the number of herds decreased by 
85% but the number of dairy cows by only 46%. As a comparison, the 
number of beef holdings was 11 900 in 2009, whit a mean size of 16 cows. 
There is a stable season and an outdoor season; farmers are bound to have all 
adult cattle on pasture during summer (at least 2–4 months, depending on 
location). There are great regional differences in herd density; it is higher in 
the southern parts of Sweden and low or sparse in the north (Figure 1). 
Veterinarians are obliged to report individual treatments, vaccinations, 
and diagnosis for all production animals to the Swedish Board of Agriculture 
via the national animal disease recording system (NADRS;  Emanuelson, 
1988). More than 90% of Swedish dairy cows are additionally enrolled in 
the Swedish official milk recording scheme (SOMRS) which record 
individual data on production and reproduction (Mörk et al., 2010; Mörk et 
al., 2009; Olsson et al., 2001). 
Sweden has a long history of successful control programs against 
infectious diseases in cattle (National Veterinary Institute, 2009). Swedish 
cattle herds are declared free from bovine herpes virus 1 and bovine 
leukaemia virus, and currently 99.8% of the cattle herds are free from 
bovine viral diarrhoea virus (BVDV) according to the rules of the national 
eradication program (Lindberg & Alenius, 1999). Mycobacterium avium 
subspecies paratuberculosis has never been detected in Swedish dairy cattle,   12
and there have only been sporadic cases in beef herds, all associated with 
imported animals.  
2.2  Bovine coronavirus 
2.2.1  Aetiology  
Coronaviruses are enveloped, single stranded and positive sense RNA virus 
of the genus Coronavirus in the Coronaviridae family (Clark, 1993). It has a 
pleomorphic to spherical shape with prominent surface projections, 
resembling the corona of the sun (Lai, 1990). The envelope consists of a 
lipid layer derived from the plasma membrane of the host cell; if this is 
disrupted, the virus completely loses its infectivity. Five major structural 
proteins are encoded, one being the spike (S) protein, which is important 
for virus-host interaction and antigenicity and is also used for comparative 
analysis in molecular epidemiology (Liu et al., 2006; Gallagher & 
Buchmeier, 2001; Kubo et al., 1994; Yoo et al., 1991). There are reports of 
small genetic differences between isolates from winter dysentery (the clinical 
name for coronavirus-induced enteritis in adults), and calf diarrhoea 
(Kourtesis et al., 2001; Dea et al., 1995; Tsunemitsu & Saif, 1995), and 
between isolates from enteric and respiratory origin (Hasoksuz et al., 2002; 
Hasoksuz et al., 1999; Reynolds et al., 1985), but no consistent antigenic or 
genetic markers have yet been identified (Saif, 2010).  
Coronaviruses are divided into three groups based on phylogeny; BCV 
belongs to the second group together with porcine haemagglutinating 
encephalomyelitis virus, equine coronavirus, and human coronavirus OC43, 
among others (Woo et al., 2009). Coronaviruses are adaptable, which has 
led to a diversity of strains and genotypes and more closely related 
coronavirus has been observed due to recent interspecies jumping. This may 
be the cause of zoonotic outbreaks with catastrophic consequences, for 
instance the severe acute respiratory syndrome (SARS) epidemic in 2003. 
2.2.2  History 
BCV was first associated with diarrhoea in calves (Stair et al., 1972), and 
serological evidence later emerged for it also being the causative agent for 
winter dysentery (Alenius et al., 1991; Emanuelson et al., 1989). This 
evidence, which was presented in 1989, confirmed previous results 
indicating this correlation (Espinasse et al., 1982; Takahashi, 1980).  
The first report of winter dysentery came from the USA in 1915 (Jones & 
Little 1931), and was followed by disease reports from several countries. In 
1946 there was an acute outbreak of winter dysentery among cattle in the   13 
south of Sweden, and by March 1948 this had spread all over the country 
(Hedström & Isaksson, 1951). 
The infection now appears to exist worldwide, with reports from Brazil, 
Turkey and South Korea among others (Brandao et al., 2006; Hasoksuz et 
al., 2005; Jeong et al., 2005), as well as from of the Scandinavian countries 
(Gulliksen et al., 2009a; Hägglund et al., 2006; Liu et al., 2006; Härtel et al., 
2004). 
2.2.3  Pathogenesis 
BCV virus enters via the oral and respiratory routes, and replicates in the 
surface epithelial cells, particularly in the lower small intestine but also in the 
colon and in the respiratory tract (Clark, 1993; Saif et al., 1986; Reynolds, 
1983). Infected cells die and are replaced by immature cells. The diarrhoea 
that follows is caused by malabsorption due to a loss of surface area, which 
decreases the digestive and absorptive capacities and leads to osmotic 
imbalance. The infection is usually self-limiting; the crypt epithelial cells are 
rarely attacked and can produce new cells resistant to virus.  
2.2.4  Clinical picture 
The clinical manifestation of BCV is watery diarrhoea, possibly mixed with 
blood, and possibly with a characteristic odour (Clark, 1993; Alenius et al., 
1991; Saif et al., 1988). The incubation period is 2–6 days, and the diarrhoea 
commonly lasts for 3–6 days. A decrease in milk yield has been described in 
both experimental (Tråvén et al., 2001) and field studies (Tråvén et al., 1999; 
Jactel et al., 1990; Saif et al., 1988). In addition to diarrhoea, various degrees 
of respiratory symptoms can occur in both calves and adults (Saif, 2010). A 
concurrent  BVDV infection has been shown to aggravate the clinical 
symptoms of BCV (Niskanen et al., 2002; Alenius et al., 1991). Treatment is 
usually not necessary, but in severe cases rehydration and rebalancing of 
electrolytes are needed (Clark, 1993).  
BCV infections has a high morbidity but usually a low mortality — it is 
effectively spread to all susceptible animals within the herd (Bidokhti et al., 
2009; Hägglund et al., 2006), and in an experimental study it was not 
possible to prevent the spread of BCV from the infected calves to the control 
group (Niskanen et al., 2002).  
 
2.2.5  Immune response 
The first antibody isotope produced after an infection is IgM, which is 
detectable in serum and milk during the acute phase from day 2–7 after 
infection and remains detectable for 3–6 weeks, as measured after an   14
experimental infection of seronegative animals (Tråvén et al., 2001). IgA is 
produced to protect mucosal surfaces from day 7–9, and by day 9-11 IgG 
antibodies can be detected in milk and serum. The IgG levels may remain 
high for at least a year after the infection even without reinfection (Alenius 
et al., 1991). Antibodies are passed to the offspring via the colostrum; these 
are detectable in the sera until approximately 5–6 months of age, and can 
disturb the immune response to a natural infection (Alenius et al., 1991; 
Heckert et al., 1991). The efficiency and duration of a naturally-acquired 
immunity is unknown (Saif, 2010). 
2.2.6  Diagnostic methods 
BCV infection can be diagnosed either directly, by detection of virus or viral 
nucleic acid in faecal samples and nasal swabs, or indirectly, by antibody 
detection in milk and serum.  
Particles of BCV can be demonstrated via direct or immune electron 
microscopy (Heckert et al., 1989; Saif et al., 1986). Isolation of BCV in tissue 
or cell culture is a technique used mainly for research purposes, since it is 
difficult and time-consuming. Reverse transcription polymerase chain 
reaction (RT-PCR) and nested PCR are sensitive methods to detect BCV RNA 
(Cho et al., 2001a).  
Detection of antibodies by indirect enzyme-linked immunosorbent assays 
(ELISA) is widely used, especially for epidemiological research such as 
prevalence studies and herd monitoring (Beaudeau et al., 2010; Hägglund et 
al., 2006; Tråvén et al., 1999; Paton et al., 1998). Isotype-capture ELISA to 
detect  BCV-specific IgA and IgM is used to distinguish primary infection 
from reinfection (Näslund et al., 2000).  
2.2.7  Epidemiology 
BCV is usually endemic in the cattle population; nationwide surveys of 
antibodies in bulk tank milk (BTM) show a prevalence of 100% in England 
and Wales (Paton et al., 1998) and 70-100% in Sweden (Tråvén et al., 1999). 
A study of 112 herds in Ithaca, New York revealed a 33% incidence over a 
9-month period (White et al., 1989). A high incidence rate of BCV among 
Swedish calves has also been shown (Hägglund et al., 2007; Hägglund et al., 
2006).  
Diarrhoea is a major health problem in calves worldwide. The association 
between diarrhoea in calves and reduced weight gain, increased mortality, 
and future reduced fertility has been quantified (Virtala et al., 1996; Wittum 
et al., 1993; Waltner-Toews et al., 1986). However, these studies did not 
focus specifically on BCV, nor did they cover adult cattle. A study of feedlot   15 
cattle have shown a decreased weight gain associated with BCV shedding 
(Cho et al., 2001b).  
BCV is shed via faeces and nasal discharge (Reynolds et al., 1985). Its 
survival outside a host has not been evaluated, but the virus is considered to 
be labile and sensitive to inactivation (Clark, 1993). Most outbreaks occur 
during the winter season; viral survival is longer when temperature and UV 
radiation levels are lower and humidity is higher (Clark, 1993; Saif, 1990). 
Increased host contacts and stress during the winter season, associated with 
the animals being housed inside, is also likely to contribute to the infection 
pattern.  
Studies on molecular epidemiology show that the virus differs between 
outbreaks both spatially and temporally, indicating that there is a new 
introduction of virus rather than latency or carrier animals (Liu et al., 2006). 
Other studies have demonstrated viral shedding in the faeces of clinically 
healthy cows (Collins et al., 1987; Crouch et al., 1985; Crouch & Acres, 
1984) which leads to the hypothesis that BCV may remain in the herd by 
means of carrier animals. Coronavirus isolated from wild ruminants in Ohio 
has been shown to be closely related to BCV and capable of infecting 
gnotobiotic calves (Tsunemitsu et al., 1995). Bovine-like coronaviruses have 
also been isolated from elk-calves, water buffalo-calves and recently from a 
giraffe (Decaro et al., 2008; Hasoksuz et al., 2007; Majhdi et al., 1997).  
2.3  Bovine respiratory syncytial virus 
2.3.1  Aetiology  
BRSV is an enveloped non-segmented negative-stranded RNA virus 
incorporated in a helical nucleocapside (Valarcher & Taylor, 2007). It is 
classified in the Pneumovirus genus of the Paramyxoviridae family. The name 
refers to the characteristic syncytia formation in cell culture due to its 
cytopathic effect (Chanock et al., 1957). The genome encodes at least ten 
proteins, of which the fusion protein and the glykoprotein play important 
roles in attachment and entry of host cells (Valarcher & Taylor, 2007).  
BRSV is closely related to the human respiratory syncytial virus (HRSV), 
which is a major cause of respiratory disease in young children (Hall, 2000; 
Van der Poel et al., 1994). Humans and cattle are considered to be the 
natural hosts of HRSV and BRSV, respectively, but antigenically-related RSV 
has been isolated in sheep and goats (Evermann et al., 1985; Lehmkuhl et al., 
1980), and antibodies to BRSV have been detected in other species (Van der 
Poel et al., 1995).   16
2.3.2  History  
HRSV was first isolated in laboratory chimpanzees in 1955 (Morris et al., 
1956). By 1960 it was clear that HRSV was an important cause of respiratory 
disease in children (Chanock et al., 1957), and ten years later BRSV was 
isolated from calves in Switzerland (Paccaud & Jacquier, 1970). In 1976 
there was an epizootic outbreak of respiratory disease in Norwegian cattle 
herds, and BRSV was isolated (Odegaard & Krogsrud, 1977). This was 
followed by only sporadic cases until 1995, when there was another 
epizootic of BRSV in central Norway (Norström et al., 2000). In 1988, BRSV 
was isolated in Sweden during an outbreak of respiratory disease in cattle 
(Elvander, 1996; Jacobsson, 1989).  
Today,  BRSV is recognised as one of the most important causes of 
respiratory disease in beef and dairy calves, both worldwide (Brodersen, 
2010; Valarcher & Taylor 2007) and in Scandinavian countries (Gulliksen et 
al., 2009b; Autio et al., 2007; Hägglund et al., 2006; Härtel et al., 2004; 
Uttenthal, 2000).  
2.3.3  Pathogenesis 
BRSV replicates in the epithelial cells of the respiratory tract (Viuff et al., 
2002). Infected cells activate an inflammatory response involving 
chemokines and cytokines; this then attracts neutrophils, macrophages, and 
lymphocytes to the airways (Valarcher & Taylor, 2007). In vitro studies have 
demonstrated a cytopathic effect of BRSV in tissue culture. However, this 
effect was absent when using epithelial cells, indicating that immune-
mediated mechanisms have a dominating impact on the pathogenesis 
(Valarcher & Taylor, 2007; Larsen et al., 2000). The infection causes an 
interstitial pneumonia, and mucopurulent exudate and haemorrhage are 
often observed in the bronchi and bronchioles (Kimman et al., 1989; Bryson 
et al., 1983).  
2.3.4  Clinical findings 
The incubation period for BRSV infections is usually between 2 and 5 days 
(Valarcher & Taylor, 2007). The clinical manifestation can involve a fever of 
40°C or higher, decreased appetite, and signs of upper and lower respiratory 
disease including coughing, nasal discharge, abdominal breathing, increased 
lung sounds, and high respiratory rate (Elvander, 1996; Harrison & Pursell, 
1985; Verhoeff, 1984). Severely affected animals can develop subcutaneous 
emphysema and die in acute pneumonia. A BVDV co-infection can increase 
the severity of a BRSV infection (Elvander et al., 1998). Respiratory viruses 
enhance bacterial colonisation of the respiratory tract, and it has been   17 
estimated that 90% of bacterial pneumonias develop after viral infection 
(Babiuk et al., 1988). Treatment includes supportive therapy, non-steroidal 
anti-inflammatory drugs, and antibiotic therapy against secondary bacterial 
pneumonia (Larsen, 2000).  
The intra-herd spread of BRSV is effective, usually all naïve animals are 
affected (Bidokhti et al., 2009; Valarcher & Taylor, 2007; Hägglund et al., 
2006); in one experimental study, the BRSV i n f e c t io n  a l so  s p r e a d  t o  t h e 
control group (Elvander et al., 1998).  
2.3.5  Immune response 
In experimentally infected colostrum-deprived calves, IgM and IgA 
antibodies were detected in serum, secretions, and faeces from day 8 post-
infection. IgG1 was detectable in serum from day 13, and IgG2 from 1–3 
months post-infection (Kimman et al., 1987). A similar response was seen in 
experimentally infected colostrum-fed calves and IgG1 titers increased 6–10 
days after infection (Uttenthal et al., 2000). Maternally-derived IgG1 
antibodies have been detected up to 6 months of age; these can largely 
suppress the humoral immune response (Baker, 1986; Kimman, 1987). 
Little or no clinical signs are observed in re-infected animals (Kimman, 
1987). Reinfection associated with increased antibody levels is commonly 
observed in younger cows, and it has therefore been hypothesised that 
immunity increases with re-exposure to BRSV (Van der Poel et al., 1995; 
Verhoeff, 1984). 
2.3.6   Diagnostic methods 
BRSV can be isolated from nasal secretions in the early stages of an infection, 
and from lung lavage and transtracheal aspirate in later stages (Larsen et al., 
1999; Van der Poel et al., 1997). Antigen can be detected by immune 
fluorescent antibody staining, which is a rapid, sensitive, and reliable test 
commonly used for clinical samples (Larsen et al., 2000). Isolation of BRSV 
in tissue culture is seldom used, since the virus is difficult to culture. RNA 
detection and amplification can be carried out by conventional RT-PCR 
assays and real time fluorogenic RT-PCR assays (Hakhverdyan et al., 2005; 
Achenbach et al., 2004; Larsen et al., 1999; Vilcek et al., 1994). 
The most commonly used methods for antibody detection are the virus 
neutralisation test and ELISA (Elvander et al., 1995).  
2.3.7  Epidemiology  
Surveys have shown an endemic spread of BRSV, with a 100% prevalence of 
antibodies in BTM in England and Wales (Paton et al., 1998) and a 41–89%   18
prevalence in Sweden (Elvander, 1996). Recent studies have shown a high 
incidence of seroconversion in Swedish beef and dairy calves (Hägglund et 
al., 2007; Hägglund et al., 2006). BRSV is one of the most important welfare 
and economic problems in the Danish beef industry, associated with a high 
mortality (15–30%) among calves and a high rate of antibiotic treatment 
(Larsen et al., 2010). 
BRSV is shed by nasal discharge and droplets, and has been observed up 
to 12 days after experimental infection (Castleman et al., 1985; McNulty et 
al., 1983; Elazhary et al., 1980; Jacobs & Edington, 1975). Since BRSV is an 
enveloped virus, it is more sensitive to inactivation compared to naked 
viruses (Baker, 1997). A study on HRSV in nasal secretions from infants 
revealed that the virus remained infectious for 6 hours on countertops, for 
1.5 hours on rubber gloves, for 30–40 minutes on clothes and tissues, and 
for 20 minutes on skin (Hall, 1982). Hand washing is known to be very 
effective at controlling HRSV (Hall, 2000). An in vitro study showed that 
generic liquid hand dishwashing detergents were 100 times more effective 
than antibacterial soaps (Contreras et al., 1999). No corresponding studies 
have been carried out for BRSV. Airborne transmission was shown in an 
experimental study designed with two separate stables connected by a tube 
in the wall (Mars et al., 1999).  
Outbreaks occur mainly during autumn and winter (Hägglund et al., 
2006; Van der Poel et al., 1993). It is not known how the virus survives 
during the summer season, but clearly there are limited options: (1) latency 
and re-activation, (2) viral circulation also during summer but at a low level, 
or (3) presence of some kind of viral reservoir. Viral sequencing showed that 
the virus was identical within herds during the same outbreak, but varied 
both temporally and spatially between outbreaks; the investigators 
concluded that there is a new introduction of virus rather than latency or 
carrier animals (Larsen et al., 2000). Van der Poel (1997) used corticosteroid 
treatment in an attempt to activate a latent infection, if present, in 
seropositive animals; there was a rise in antibody titre, but sentinels were not 
infected and the virus was not isolated. Valarcher et al. (2001) demonstrated 
BRSV persistence in lymph nodes up to 71 days after an experimental 
infection of calves. 
2.4  BCV and BRSV vaccines 
Live vaccines against BRSV are used around the world, but their efficiency 
has been questioned (Larsen et al., 2001; Valarcher et al., 2000). There is also 
a risk that live vaccines may become contaminated by other pathogens such   19 
as BVDV (Falcone et al., 2003; Barkema et al., 2001). A report from Belgium 
describes deaths of respiratory distress among calves being vaccinated with 
inactivated  BRSV vaccine (Schreiber et al., 2000). Formalin inactivated 
vaccine against HRSV and BRSV have shown to enhance disease in infants 
and cattle respectively (Brodersen, 2010). 
There is one commercial vaccine available for BCV; a combination of 
inactivated vaccine against diarrea caused by BCV, rotavirus, and Escherichia 
coli that is mainly used in beef cattle herds. There are, so far, no vaccines to 
prevent  BCV induced respiratory disease in cattle (Saif, 2010). The only 
vaccine against BRSV that is commercially available in Sweden is an 
inactivated combination vaccine for against BRSV, Mannheimia heamolytica, 
and bovine parainfluensa virus 3, which was found to be inadequate in a 
recent study (Larsen et al., 2010). Experimental trials with immune-
stimulating complex (ISCOM) vaccines against BRSV have shown promising 
results, but these vaccines are not yet commercially available (Hägglund et 
al., 2004). New sophisticated vaccines are oncoming with a molecular 
approach i.e. use of DNA as a part of the composition (Brodersen, 2010). 
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3  Aims 
 
The overall aim of this research was to gain further knowledge of the 
epidemiology of BCV and BRSV infections in Swedish dairy herds.  
 
The specific aims were: 
  
   to study the effects of BCV and BRSV infections on milk yield, 
reproduction, and herd health parameters; 
 
   to evaluate possible risk factors for the inter-farm spread of BCV 
and BRSV; 
 
   to investigate the possibility of controlling BCV and BRSV 
infections in dairy herds via biosecurity measures; 
 
   to describe the long-term dynamics of BCV and BRSV infections 
in dairy herds; and 
 
   to study the prevalence of antibodies and frequency of 
conversions in pooled milk samples of primiparous cows and 
BTM.  
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4  Materials and Methods 
This section summarises the overall issues regarding study populations, data 
collection, and research methods. A more detailed description is given in 
each individual paper (I-IV). 
4.1  Study populations 
We aimed to include 280 herds within seven areas of Sweden as study 
population. The areas were located within the counties of Halland, Kalmar, 
Öland, Gotland, Jämtland, and Västerbotten. These counties were selected 
for two reasons; (1) previously-estimated differences in the prevalence of 
BCV and BRSV antibodies in BTM; 90–100% and 84–89% respectively in 
Halland and Gotland, and 70–79% and 41–51% respectively in Jämtland and 
Västerbotten (Tråvén et al., 1999; Elvander, 1996), and (2) structural 
differences.  
Three different selection strategies were applied. In the counties of 
Halland, Gotland, Jämtland, and Västerbotten, we selected a convenience 
sample of ten herds with 30–80 cows and ten herds with more than 80 
cows. From Kalmar, Öland, and two neighbouring veterinary districts in 
Uppland, we included approximately 50 herds, representing the majority of 
the existing herds within a limited geographical area. Finally, we included 
20 herds distributed throughout Sweden, each with at least 180 cows, 
owned by farmers who were considered by the local veterinarian to be 
progressive farmers with high management skills. These herds are henceforth 
referred to as the “special group”.  
Herds were eligible for inclusion if they were members of the local 
livestock association and enrolled in NADRS and SOMRS (Olsson et al., 2001; 
Emanuelson, 1988). All herds were free from BVDV according to the rules of 
the Swedish eradication program (Lindberg & Alenius, 1999).   24
For studies I and II we used the herds located in Uppland as study 
population, for study III all herds were included, and for study IV we used 
the herds located in Halland, Gotland, Jämtland, and Västerbotten.  
 
 
 
 
(a)    (b) 
Figure 1. Maps of Sweden, showing (a) the density of dairy farms (expressed as the number of 
farms per 100 square kilometres) recorded by the Swedish Board of Agriculture in 2005, and 
(b) the locations of the study herds in the seven study areas; G: Gotland, H: Halland, J: 
Jämtland, K: Kalmar, Ö: Öland, U: Uppland, V: Västerbotten. The stars represent the herds 
referred to as the special group, defined in the text.  
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4.2  Sampling 
The herds were sampled before (September/October) and after (April/May) 
the winter season over three years, September 2006 to May 2009. A pooled 
milk sample from five home-bred primiparous cows and a BTM sample were 
obtained from each herd at each of the six sampling occasions, except for 
the Uppland areas and the special group. For these, we used the samples 
from the monthly milk recording scheme collected by Steins laboratory in 
spring 2008 and spring 2009, with the samples originating from primiparous 
cows being pooled by herd. These herds were not sampled in autumn 2008. 
The individual samples from primiparous cows were additionally used to 
evaluate the correlation between individual and pooled milk samples 
(Ohlson et al., 2009).  
4.3  Antibody detection   
The milk samples were analysed for the presence of IgG antibodies to BCV 
and BRSV, using commercially available indirect ELISAs (Svanova biotech) 
(Elvander et al., 1995; Alenius et al., 1991). The optical density (OD) at 450 
nm was corrected by subtraction of the negative control antigen OD. To 
adjust for possible day-to-day variations we calculated the percent positivity 
(PP) using the following formula: (corrected OD/positive control corrected 
OD) × 100. For the BTM samples, a PP value of < 5 was considered as 
negative. This closely corresponds to the corrected OD of 0.05 which has 
previously been used as a cutoff for detection of BCV and BRSV antibodies in 
BTM (Tråvén et al., 1999; Paton et al., 1998; Elvander, 1996). For the 
pooled milk samples, a PP value of < 20 was regarded as negative, closely 
corresponding to the corrected OD of 0.20 which is the cutoff for negative 
individual milk and serum samples as recommended by the manufacturer.  
The sensitivity is estimated to be 84.6% for BCV and 94.6% for BRSV and 
the specificity to be 100% for both, according to the manufacturer’s manual. 
The estimates for BRSV are based on a parallel analysis with the ELISA used at 
the National Veterinary Institute, Sweden and the ELISA used at the Central 
Veterinary Laboratory, England (Elvander et al., 1995). The BCV ELISA was 
developed by Alenius et al. (1991), with estimates of sensitivity and 
specificity based on a comparison between the ELISA and a virus 
neutralisation test. In Elvander et al (1995) there was a good agreement 
between milk and serum samples regarding IgG antibody titer to BRSV, and 
unpublished data confirms this for both BRSV and BCV.    26
We used 10 ml test tubes containing 1.5 mg of the preservative agent 
Bronopol (2-bromo-2-nitropropane-1.3-diol). The samples were not 
diluted or centrifuged, and were stored at -20°C until analysis. 
4.4  Information provided to farmers 
The farmers were informed by mail regarding the antibody status 
(positive/negative) of the herd based on the pooled milk sample, and those 
with antibody-negative herds were encouraged to let visitors know their 
status. All farmers received basic information regarding clinical symptoms, 
and advice on how to protect their herd via biosecurity routines regarding 
visitors and purchase of animals. The local veterinarian also received the 
results of each sampling occasion. 
4.5  Questionnaires 
In connection to spring sampling in 2007 and 2008, the farmers completed a 
questionnaire in which they were asked to declare the occurrence of any 
clinical signs which could be related to BCV or BRSV infections, defined as 
signs of diarrhoea or respiratory disease affecting at least 25% of the cows 
within 1 week. These questionnaires were used in study II, to evaluate the 
effects of BCV and BRSV infections on individual performance.  
In spring 2007, the farmers also completed a questionnaire on herd 
routines; this was used in study III to quantify the effects of potential risk 
factors on seropositivity to BCV and BRSV. 
4.6   Additional data 
Herd data on milk production, SCC, disease records, reproductive 
performance, and disease incidence were acquired from SOMRS and NADRS. 
For study I we used herd-level data from September 1
st 2005 to August 31
st 
2006, and for study II we used individual data from September 1
st 2006 to 
May 31
st 2007 and from September 1
st 2007 to May 31
st 2008. 
To facilitate  spatial analysis in study III, the geographical X and Y 
coordinates of the herds were obtained from the Swedish Board of 
Agriculture.    27 
4.7  Statistical methods 
In study I, we used linear and logistic regression models to assess differences 
between antibody-positive and antibody-negative herds regarding herd 
health and other herd characteristics. The outcome variable was the 
parameter of interest, and the explanatory variables were antibody status 
(defined as 0 if negative to both BCV and BRSV and 1 otherwise) and other 
variables of biological importance for the outcome.  
In study II, we used multilevel linear and logistic regression models to 
evaluate possible differences in individual milk yield, SCC, and reproductive 
performance between the defined groups (based on antibody status before 
and after the winter season and the presence/absence of clinical signs). Each 
model had performance as outcome variable and the defined BCV/BRSV 
status groups together with factors known to influence the performance 
under study as explanatory variables. Cow and herd were included as 
random effects to account for repeated measurements and within-herd 
cluster respectively. Differences between the groups in young stock 
mortality were evaluated with the Cox proportional hazard model. The data 
were fitted by using the robust sandwich estimate in order to account for 
clustering within the herd.  
To quantify the effects of potential risk factors for seropositivity in study 
III, we used logistic regression models with antibody status as outcome 
variable (defined as 0 negative and 1 positive) and herd level factors obtained 
in the questionnaires as explanatory variables. We also used two spatial 
analysis techniques: the K-function and Moran’s I statistic. Each herd was 
considered as a point according to its X and Y coordinates. The K-function 
was used to test if there was aggregation of antibody-positive herds over 
negative, and Moran’s I statistic was used to identify the possible presence of 
dependency (autocorrelation) in the residuals between neighbouring herds.  
In study IV, we used multilevel logistic regression models to evaluate 
possible seroconversion differences between the areas; seroconversion was 
the outcome variable (with 0 defined as no seroconversion and 1 defined as 
seroconversion) and area, season, and herd size were the explanatory 
variables. Herd was included as a random effect to correct for repeated 
measurements.  
Statistical analyses were performed using the statistical software Stata 
(Stata statistical software: Release 9.2 and 10.0; College Station, TX, USA: 
StataCorp  LP.),  SAS ( SAS Institute Inc., Cary, NC), and R ( TEAM, 2008). 
Maps were generated using R and the geographical information system 
software ArcView version 9.1 (ESRI Inc., Redlands, California, USA). 
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5  Results & discussion 
This chapter provides a summary and general discussion of the results, 
together with methodological considerations. A more detailed discussion is 
given in each individual paper. 
5.1  Health and performance  
The main findings associated with herd health and performance were:  
 
   Herds that were antibody-positive to BCV and/or BRSV had a 
significantly higher BTMSCC compared with herds that were 
negative to both BCV and BRSV (median cells/ml:  218 000  and     
163 000 respectively). All other health variables analysed were in 
favour of the antibody-negative herds, though the differences were 
not statistically significant (I). 
   Cows in herds recently infected with BRSV (seroconverting from 
negative to positive) and cows in herds where the farmer reported 
clinical signs suggestive of a BRSV outbreak had a significantly lower 
milk yield (0.57 and 0.91 l/day, respectively) compared with cows 
in antibody-negative herds (II). 
   Cows in herds where the farmer reported clinical signs of a BRSV 
outbreak had a significantly higher SCC (12.000 cells/mL) compared 
with cows in herds without clinical signs of BRSV (II). 
 
One concern relevant to the present thesis is whether the lower 
BTMSCC/SCC and higher milk yield among antibody-negative herds was a 
direct effect of infection, or whether the results were confounded by 
management factors. A disadvantage of cross-sectional studies is that they are 
not particularly useful in evaluating causal associations. Well-managed herds   30
are more likely to have a lower SCC, a higher milk yield, and a higher level 
of biosecurity measures (i.e. avoiding introduction of contagious infections). 
We believe, however, that these results are not solely a reflection of 
management differences. The absence of these infections for at least two 
years, as indicated by antibody-negative primiparous cows, is likely to be 
associated with a truly positive effect on herd health. The medians for all 
other analyzed health and reproductive parameters in study I were 
consistently in favour of the herds negative to both viruses although the 
differences were not statistically significant. Median herd size was 
numerically higher amongst the herds in the negative group (57) compared 
to the herds positive to BCV and/or BRSV (43).  
The antibody-positive herds investigated in study I had been infected at 
least around 2 years prior to the sampling time, and the data used in the 
analysis was 1-year retrospective. In study II, the analysis covered data from 
a 7-month period; we know that the herd was infected during this time, but 
not when. In addition, the antibody status was measured on a herd level, 
and older cows might have immunity to these infections. In the light of this, 
the difference between the defined groups in studies I and II might be 
underestimated.  
The disease and reproduction data collected from NADRS and SOMRS 
were reported by farmers, AI technicians, and veterinarians. The farmers 
were not necessarily homogeneous in either their willingness to report or 
the criteria used to decide whether to call out a veterinarian. It is possible 
that farmers of well managed herds are better at reporting and well managed 
herds might also have a higher biosecurity level and are therefore more 
likely to avoid infectious diseases. A recent evaluation of the validity of 
NADRS (Mörk et al., 2010) revealed a moderate correspondence between 
manual herd registers and the NADRS database. However, it is unlikely that 
antibody status of a herd would systematically affect the veterinarians’ and 
technicians’ level of reporting. In additions, the major findings were related 
to  BTMSCC, individual SCC, and milk yield, which are objective 
measurements.  
It is likely that antibody negativity to BCV and/or BRSV as well as a 
recent infection would have similar effects on the analysed parameters also 
in dairy herds located in other parts of Sweden, and the target population 
for study I and II is therefore all Swedish dairy herds.  
In addition to the data analysed in studies I and II there exist unpublished 
data from the questionnaires in which the farmers described outbreaks 
possibly related to BCV and BRSV infections. The results are summarised in 
Table 1. Among the herds experiencing enteric disease, 28% seroconverted   31 
from antibody-negative to antibody-positive in the pooled milk samples, 
while 94% of those experiencing respiratory disease seroconverted to BRSV. 
This could be associated with fewer differential diagnoses for respiratory 
signs compared to diarrhoea, but could also reflect a difference in protective 
immunity between BCV and BRSV. Van der Poel et al. (1995) concluded in 
an observational study that there were neither clinical signs of disease nor a 
significant drop in milk yield associated with BRSV reinfection, as measured 
by increased antibody titer.  
 
Table 1. Summary of 2007 and 2008 questionnaire data in which farmers described possible outbreaks 
of bovine coronavirus (BCV) and bovine respiratory syncytial virus (BRSV) and their suspicion of 
transmission routes; number of herds for each parameter. Only estimates from herds that seroconverted 
from antibody negative to positive in a pooled milk sample of primiparous cows are shown.  
Description BCV  BRSV  Transmission  BCV  BRSV 
Clinical signs  94  16  Unknown  11  5 
Seroconverted 26  15  Visitor  7  6 
Drop in milk yield  25
a 10
b Slaughter  lorry  4  2 
Veterinary visit  6  6  Milk lorry  2  1 
Abortion 4  4  Airborne  1  1 
Dead calves  3  1
c Animal  introduction  1  0 
Dead cows  3  1
c      
a  5-50% decrease (median 20%) in bulk tank milk for 1-5 weeks (median 2 weeks). 
b 5-20% decrease (median 15%) in bulk tank milk for 2-5 weeks (median 2 weeks). 
c One herd had three dead calves, two dead cows, and two abortions. 
5.2  Between-herd transmission 
The main findings related to inter-farm transmission were:  
 
   A significantly higher proportion of herds antibody-negative to BCV 
used external technicians for artificial insemination instead of farm 
personnel (29/33), compared to their antibody-positive counterparts 
(28/46; I). 
   Antibody-positive farms were not spatially aggregated over 
antibody-negative farms, regarding either BCV or BRSV (III). 
   Large herd size, being located in southern Sweden, and not 
providing boots for visitors were found to be associated with 
antibody positivity to BCV and BRSV. Short distance to nearest cattle 
herd was also associated with antibody positivity to BCV (III).   32
The positive association between external technicians and BCV antibody 
negative herds may seem contradictory, but also suggest that it is possible to 
avoid infection even in a herd which has regular visitors. In the Uppland 
area, a typical 50-cow herd has two technician visits per week, and a 
technician visits approximately six herds per day. The result is in agreement 
with a study by Bidokhti et al. (2009), where the use of external technicians 
for insemination was significantly associated with BCV and BRSV antibody-
negative herds.  
The lack of spatial autocorrelation indicates that local spread and airborne 
transmission are not the most important factors for the inter-farm spread of 
BCV and BRSV,  at least not in areas with moderate herd density under 
Swedish conditions.  
Not providing boots for visitors was the only management factor 
associated with antibody positivity in study III. We believe that providing 
boots for visitors and always using them strongly symbolises farms with high 
biosecurity measures, and this therefore lend support to the hypothesis that 
herds antibody-negative to BCV/BRSV are significantly different from 
antibody-positive herds regarding biosecurity measures.  
Region was associated with antibody positivity to BCV and BRSV, with 
decreasing odds ratios moving from south to north. The results from 
Moran´s I showed, that the unexplained variance (the model residuals) was 
not due to spatially-correlated factors. In a recent nationwide study on 
Swedish beef herds, there were a positive association between herd density 
and prevalence of BCV and BRSV, however, a high density area with low 
prevalence was also identified and the investigators therefore concluded that 
other factors than herd density, such as regional differences in biosecurity 
and management routines, have impact on the prevalence of BCV and BRSV 
(Beaudeau et al., 2010). The additional significant factor for BCV, distance to 
nearest cattle herd, was not significant for BRSV. This difference could be 
explained by the fact that BCV is shed via faeces, which might be more easily 
spread between herds than nasal discharge.  
The seven areas chosen as source population in study III were selected to 
reflect the target population; dairy herds in Sweden. The source population 
is reasonably valid for the target population. The main consideration is 
whether the study population reflects the source population (and hence the 
target population) since the herds included were randomly selected which 
may have influenced the internal validity. For Uppland, Kalmar and Öland 
this should not affect the results inasmuch as the majority of the existing 
herds within limited areas were included. In Halland, Gotland, Jämtland and 
Västerbotten, the selection could lead to a bias, but because the antibody   33 
status of the herds was unknown before sampling and the selection was not 
based on management skills or lack thereof, we do not regard this as a major 
concern. The 16 herds selected to go into the special group, however, could 
be seriously biased by selection. The results of the analyses remained 
unchanged, however, when the models were run without these herds. 
In the outbreak questionnaires, we asked the farmers about possible 
transmission routes (Table 1). There was only one report of animal 
introduction for BCV and no such reports for BRSV. This suggests a 
difference in epidemiology between these viruses and BVDV, which is also an 
enveloped virus. BVDV seems to spread primarily by direct contact, and the 
control program in Scandinavia has been successful by targeting animal 
movements (Lindberg & Houe, 2005).  
5.3  Long-term dynamics of BCV and BRSV 
The results of study IV show that the long-term dynamics of BCV and BRSV 
differed between the herds located in the two southern areas (Halland and 
Gotland) and the herds in the two northern areas (Jämtland and 
Västerbotten). In the southern areas the percentage of antibody positive 
herds (pooled milk sample) was continuously at a high level (85–100%), 
whereas in the northern it varied for BCV from 38% to 80% and for BRSV 
from 0% to 80%. At the last sampling occasion, there was evidence of self-
clearance for BRSV in the Jämtland area. This might be due to natural 
fluctuation, but could also be the result of higher awareness and improved 
biosecurity measures in these herds. It is possible that the restriction on 
animal movement from southern Sweden, due to blue tongue virus, also 
contributed to this positive development.  
During the study period, there was evidence of self-clearance in herds 
manifesting as a change in antibody status from positive to negative in the 
pooled milk sample; 28 times in 27 herds and 32 times in 32 herds for BCV 
and BRSV respectively. Two herds were antibody negative to BCV in BTM 
and four herds to BRSV throughout the study period. In addition, three 
herds for BCV and three herds for BRSV became antibody negative in BTM 
during the study period. These herds were all located in Jämtland and 
Västerbotten, except one herd negative to BCV that was located in Halland. 
One of these herds, located in Västerbotten, became positive to BCV 
whereas the other herds remained negative. One herd in Jämtland, 
comprised of 147 milking cows, was antibody negative to BCV and BRSV in 
BTM throughout the study period.    34
The results from the logistic regression models showed differences 
between  BCV and BRSV regarding conversions from antibody negative to 
positive. For BCV, there were no differences between the areas or between 
the two herd-size groups. Conversely, for BRSV the new infection risk was 
greater in the two southern areas compared to the north, and also greater in 
larger herds (>80 cows) compared with herds of average size (30-80 cows). 
Herds negative in the pooled milk sample had been free from the infections 
for at least two years. This indicates that in herds seroconverting from 
negative to positive there was a new introduction of virus rather than a 
continuous within-herd circulation or activation of virus from carrier 
animals.  The risk of converting from negative to positive was higher during 
the winter season for both infections. A few conversions were observed 
between April/May and September/October suggesting that there might 
also be a circulation of the virus, albeit at a low level, during the summer 
(outdoor) season.  
The results of study IV support our hypothesis that it is possible to 
establish herds free from BCV and BRSV. The hypothesis that areas can have 
self-clearance of BRSV cannot be rejected, while the corresponding situation 
for BCV needs further investigation. The target population was herds located 
in areas with similar structure and similar prevalence of BCV and BRSV, i.e. 
southern and northern parts of Sweden. 
 
For Kalmar (40–50 herds) and Öland (50–52 herds) the percentage of 
antibody positive herds to BCV in the pooled sample was 80–90% and 88–
98% respectively, for the six sampling occasions. Corresponding number 
were 57-75% for Uppland (36-90 herds) and 75-89% for the special group 
(11-20 herds); two herds were antibody negative to BCV in the pooled milk 
sample throughout the study period, consisting of 220 and 300 cows located 
in central and northern Sweden respectively.  
For BRSV, the percentages of antibody positive herds in the pooled milk 
sample were; 78–92% for Kalmar, 94–100% for Öland, 75–81% for Uppland 
and 63–82% for the special group.  
5.4   Antibody detection in pooled milk samples and BTM  
The relationship between antibody status in individual and in pooled milk 
samples was evaluated using the individual samples collected from 64 herds 
in Uppland by Steins laboratory (Ohlson et al., 2009). Ten milk samples 
were randomly selected from each herd. In the majority of the herds with 
mixed results there was a clear age difference; cows with lower lactation   35 
number were antibody-negative and older cows antibody-positive. The 
primiparous cows were pooled by herd, with 3–5 cows in each pool. None 
of the pooled milk samples that consisted of 100% negative individual 
samples were positive, and none of the pooled samples that consisted of 
100% positive individual samples were negative, regarding both BCV and 
BRSV (Figure 2). In the majority of the herds (83% for BCV and 74% for 
BRSV), all primiparous cows were either all positive or all negative. 
 
 
  
(a) (b) 
Figure 2. The y-axis shows the percent positivity (PP) value of IgG antibodies to (a) bovine 
coronavirus (BCV) and (b) bovine respiratory syncytial virus (BRSV) in pooled milk samples 
of 3-5 primiparous cows, and the x-axis shows the corresponding percentage of positive 
individual samples included in the pooled sample. The dashed line is the cutoff at a PP value 
of 20.  
In study IV, we evaluated the association between the antibody titre in BTM 
and the status of the younger cows. We used 432 pooled samples from 
primiparous cows with corresponding BTM. All BTM samples that were 
antibody-negative (PP<5) had a corresponding negative pooled sample 
(PP<20). In addition, for both BCV and BRSV the median PP in BTM was 
lower in the samples that had a negative corresponding  pooled  sample       
(t-test,  P<0.001); this difference remained significant when the BTM-
negative samples were excluded. The majority of the negative pooled 
samples, however, had a corresponding positive BTM sample.  
Our conclusion is that detection of antibodies to BCV and BRSV in BTM 
is a good method for estimation of herd exposure historically or in areas 
where the viral circulation has been very low or absent for some time. The 
use of pooled milk samples is a favourable approach for identifying 
susceptible herds in early control programs in endemic areas and for animal 
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trading. It is crucial that the cows included in the pool are home-bred, in 
order to get a true reflection of the herd status. 
5.5  Prospects for control 
5.5.1  Possibility of controlling the spread of BCV and BRSV 
The findings reported in this thesis indicate that local factors such as daily 
visiting milk trucks, wild animals, and airborne transmission are unlikely to 
be major important transmission routes of BCV and BRSV infections. We 
believe that contacts through networks (visitors, equipments etc) are more 
important for the inter-farm spread of these viruses. Therefore, it seems clear 
that there is a possibility of controlling the spread of BCV and BRSV in a 
cost-effective and practical way via increased biosecurity.  
Jämtland was likely to be free from circulating BRSV in the end of the 
study period. This demonstrates that it is possible to have self-clearance of 
BRSV, that is, clearance without strict intervening activities such as 
vaccination or regulation of transport and contacts, not only within a herd 
but also within an area. Although no clearance of BCV occurred in any of 
the studied areas, the prevalence of antibodies in the pooled milk samples 
was low among the study herds in Jämtland in 2007 and in Västerbotten in 
2008. In addition, study IV revealed self-clearance (via conversion from 
antibody-positive to antibody-negative in the pooled sample) in herds, for 
both of BCV and BRSV.  
Given that Sweden and the other Scandinavian countries have 
successfully eradicated BVDV, a possible and tempting challenge would be to 
establish areas with freedom from BCV and BRSV. To our knowledge, there 
have been no previous efforts to establish BCV or BRSV free herds on a 
regional or national level. 
5.5.2  Proposals for controlling the spread of BCV and BRSV 
The current situation in the northern parts of Sweden is appropriate for the 
initiation of a voluntary control program based on increased awareness and 
biosecurity measures targeting indirect contacts and purchase of animals. In 
this program, the antibody status of the herds would be monitored before 
each winter season. Pooled milk samples from primiparous cows would be 
preferable at the start, but could be replaced by BTM monitoring once 
freedom from infection is established. Detecting antibodies to BCV and 
BRSV in milk samples by an indirect ELISA is cheap, and the samples are easy 
to collect. The farmers would receive information on their BCV and BRSV 
antibody status, along with biosecurity advice. All veterinarians, technicians,   37 
and others that frequently visit dairy herds in the area would be informed 
about the program, provided with basic information on BCV and BRSV 
infections, and advised on good biosecurity routines. These 
recommendations would be developed together with farmers, veterinarians 
and other professions in the field in order to achieve a high level of 
implementation.  
Our hypothesis is that with increased biosecurity, the basic reproduction 
rate for the transmission of BCV and BRSV between herds in a susceptible 
population will be below one, and therefore the infection spread will be 
halted. An outbreak of BCV  or BRSV in the study area would be easily 
detected, since all farmers and all professionals in the field would be 
involved in the project. Information about herd antibody status is likely to 
increase the interest in biosecurity and the acceptance of new routines.  
5.5.3  Benefits of preventing BCV and BRSV infections 
We believe that it is not consistent with a sustainable healthy cattle 
population to have BCV and BRSV outbreaks every year when there is a 
possibility of controlling the spread. Despite the fact that routines related to 
good biosecurity have been recommended for many years (Larsson et al., 
1995), and that due to the BVDV program Swedish farmers are probably 
more aware of and more likely to practise these measures than farmers in 
many other countries, a recent survey revealed that there is still a need for 
improvement (Nöremark et al., 2010). Increased biosecurity would not only 
prevent the spread of BCV and BRSV, but also make Swedish cattle farms 
better prepared for future epizootics and prevent the spread of zoonotic 
infections as well as other contagious infections. Due to the contagious 
nature of BCV and BRSV, they are good indicators of biosecurity at the farm 
level. A reduced incidence of BCV and BRSV outbreaks would benefit the 
farmer economically, enhance animal welfare, and reduce the use of 
antibiotics.  
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6  Conclusions 
   Herds that were antibody-negative to both BCV and BRSV had a 
lower BTMSCC compared to farms that were antibody-positive to 
BCV and/or BRSV. Cows in recently BRSV-infected herds had lower 
milk yield and higher SCC compared to cows in BRSV-free herds.  
 
   BCV and BRSV antibody-positive herds were not spatially aggregated 
compared to antibody-negative herds, indicating that local spread 
and airborne transmission are not the most important factors for the 
inter-farm spread of BCV and BRSV,  at least not in areas with 
moderate herd density under Swedish conditions. 
 
   Providing boots for visitors and ensuring that these boots were 
always used was associated with a lower herd prevalence of both 
BCV and BRSV; this factor is likely to reflect a high level of 
biosecurity and indicates that the introduction of virus into a herd is 
not just by chance. 
 
   There was evidence of self-clearance of BRSV within an area; that is, 
clearance without strict intervening activities such as vaccination or 
regulation of transport and contacts, but with increased awareness 
and biosecurity recommendations.  
 
   The results of this thesis suggests that it is possible to develop 
inexpensive strategies for controlling BCV and BSRV infections, 
based on biosecurity and antibody monitoring.  
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7  Further research 
 
   Studies regarding the attitudes of farmers and veterinarians towards 
new information in the veterinary field in general and new 
information on biosecurity in particular would be highly desirable. 
In order to achieve widespread adoption of recommendations 
gained from research, there must be a strategy for communicating 
with the farmers and veterinarians and ensuring their ongoing 
engagement in the research process. Farmer participation in crucial 
phases of the research, beginning with problem formulation, testing 
of options in the field, and the implementation of control or 
prevention measures, would ensure that the research findings are 
meaningful to the end users, that new knowledge is made available 
in forms appropriate to a wide cross-section of the farmers, and 
most importantly, that the outcomes are implemented in their 
herds.  
 
   A study to investigate the possibility of establishing long-term 
freedom from BRSV and BCV within a geographical area, via 
increased biosecurity, would give evidence for the possibility of 
cattle production without these viruses, and also allow evaluation of 
the effect on the incidence of other contagious infections.  
 
   Another valuable research route would be to investigate BCV and 
BRSV outbreaks using reliable dates for the onset and only including 
seroconverting animals, in order to accurately quantify the short-
term and long-term loss of production and reproduction 
performance on an individual level.  
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   One way to obtain deeper knowledge regarding the epidemiology 
of BCV and BRSV infections would be to use molecular analysis for 
contact tracing. This technique was successfully used in the final 
phase of the Swedish BVDV programme. 
 
   Development of efficient vaccines against BCV and BRSV infections 
would be desirable. A vaccine could be used alongside biosecurity 
measures to reduce the infection pressure, especially in larger farms 
that frequently introduce new animals.  
 
   Routine collection of pooled milk samples of primiparous cows 
from the milk recording scheme is technically feasible and would 
provide excellent and unique possibilities for nationwide 
epidemiological studies of BCV and BRSV and for the control of 
these infections. 
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8  Populärvetenskaplig sammanfattning 
8.1  Bakgrund 
Varje år drabbas ett stort antal svenska mjölkkobesättningar och besättningar 
i den specialiserade köttproduktionen av infektioner med bovint coronavirus 
(BCV) och bovint respiratoriskt syncytialt virus (BRSV).  BCV ger upphov till 
diarré hos kalvar och vuxna djur (vinterdysenteri) och kan även orsaka 
varierande grad av luftvägssjukdom.  En infektion med BRSV ger hög feber 
och luftvägssjukdom och det händer att djuren dör i akut lunginflammation. 
Drabbade djur behandlas ofta med antibiotika pga. sekundära bakteriella 
lunginflammationer. Några bevisat säkra och effektiva vacciner mot dessa 
virusinfektioner finns för närvarande inte tillgängliga. 
Rapporter  visar att BCV och BRSV är spridda över hela världen.   
Förekomsten av antikroppar i tankmjölk var 100% för BCV och BRSV i 
England och Wales, i Sverige har motsvarande studier visat en förekomst på 
70-100% för BCV och 41-89% för BRSV.  
BCV  och  BRSV är smittsamma infektioner och oftast infekteras alla 
mottagliga djur i besättningen. Smittspridingen mellan besättningar sker både 
direkt från djur till djur och indirekt via t.ex. besökare och redskap. De är 
känsliga för avdödning med desinfektionsmedel och överlever inte någon 
längre tid utanför djuret. 
Den nuvarande uppfattningen bland många djurägare och veterinärer är 
att det inte går att förhindra smittspridning mellan besättningar, och att det 
är bra med upprepade infektioner för att upprätthålla djurens immunitet. 
Observationer visar dock att det finns mjölkbesättningar som tack vare bra 
smittskyddsrutiner och en medveten hållning har hållit sig fria från BCV och 
BRSV infektioner i åratal. Ett utmärkande drag för dessa besättningar är att de 
uppvisat en hög produktion och en god kalvhälsa. 
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8.2  Sammanfattning av avhandlingsarbetet 
Det övergripande syftet med avhandlingsarbetet var att få ytterligare kunskap 
om BCV och BRSV infektioners epidemiologi i Svenska mjölkbesättningar.  
Vi inkluderade besättningar från Halland, Gotland, Jämtland och 
Västerbotten (ca 20 från varje område) samt Kalmar, Öland och två områden 
i Uppland (ca 50 från varje område, motsvarande majoriteten av de 
befintliga mjölkbesättningarna inom ett begränsat område) och slutligen ca 
20 gårdar spridda över Sverige mer än 180 kor och som den lokala 
veterinären ansåg vara i frontlinjen vad det gäller skötsel och kunskap. 
Vi samlade in samlingsprover på mjölk från fem förstakalvare och 
tankmjölksprover före och efter stallsäsongen under tre år (2006-2009). Efter 
en genomgången infektion är antikroppar mätbara under lång tid, 
tankmjölken speglar därför långtidshistoriken medan ett samlingsprov på 
förstakalvare visar om besättningen varit utsatt för smitta de senaste två åren. 
Proverna analyseras på förekomsten av antikroppar mot BCV och BRSV med 
ELISA. Efter varje provtagning fick djurägarna veta besättningens 
antikroppsstatus (negativ/positiv) tillsammans med information om 
infektionerna och smittskyddsråd. I informationen till djurägarna samt i 
studie I-IV baserades besättningarnas antikroppsstatus på samlingsprovet av 
förstakalvare. 
 
Hälsoparametrar och mjölkavkastning  
I den första delstudien utvärderades association mellan antikroppsstatus och 
hälso- och reproduktions parametrar på besättningsnivå. Vi använde oss av 
besättningarna från de två uppländska områdena. Tio besättningar som var 
antikroppsnegativa mot både BCV och BRSV jämfördes med 69 besättningar 
som var positiva mot BCV och/eller BRSV. Besättningsstorleken (median) var 
för de negativa besättningarna 57 kor och för de positiva 43 kor. Data 
analyserades ett år retrospektivt från provtagningstillfället. Vi fann att de fria 
gårdarna hade lägre celltal i tankmjölken, med statistisk signifikans (median 
163 000 celler/mL och 218 000 celler/mL) mätt över en ettårs period. De 
fria besättningarna låg konsekvent bättre till på alla analyserade hälso- och 
reproduktionsparametrar, jämfört med de antikroppspositiva besättningarna, 
men skillnaden var inte tillräckligt stor för att vara statistiskt säker.  
I den andra studien analyserades data på individnivå, gällande 
mjölkavkastning, mjölkens celltal, reproduktions parametrar och mortalitet 
hos ungdjur, inkluderande 65 uppländska mjölkgårdar. Kor i besättningar 
som nyligen haft en BRSV infektion hade signifikant lägre mjölkproduktion 
jämför med antikroppsnegativa gårdar (0,7 liter per dag och ko mätt över en 
7-månaders period). I besättningar där djurägaren noterat kliniska symptom   45 
på BRSV infektion hade korna en signifikant högre cellhalt i mjölken jämfört 
med kor i besättningar utan rapporterade symptom (18 000 celler/mL högre 
i snitt vid varje mätning).  
 
Smittspridning mellan besättningar  
I studie 1 hade 88% av de BCV negativa besättningarna externa seminörer 
istället för egen semin, detta var en signifikant högre andel jämfört med de 
BCV positiva besättningarna (61%). Detta indikerar att seminörerna i 
upplandsområdet hade ett fungerande smittskydd men kan också spegla att 
de besättningar som använder sig av professionella seminörer var mer 
noggranna med sina skötselrutiner. Resultatet visar att det är möjligt att hålla 
sig fri från BCV infektion trots regelbundna besök.  
I den tredje studien identifierades riskfaktorer för BCV och BRSV 
introduktion, genom att jämföra rutiner mellan antikroppsnegativa och 
antikroppspositiva besättningar. I denna studie ingick 257 gårdar från alla 
områden. Att tillhandahålla stövlar för besökare som alltid används var en 
skyddande faktor för både BCV och BRSV. Detta var den enda skötselfaktor 
som var signifikant associerat med antikroppsstatus och vi anser att den 
speglar en hög nivå av smittskydd. Vi undersökte även den geografiska 
spridningen genom spatial analys och fann att smittade gårdar inte bildade 
kluster jämfört med negativa gårdar. Detta fynd indikerar att luftburen och 
lokal (t ex via gnagare) smittspridning inte är av den viktigaste vägen för 
överföring av BCV och BRSV mellan gårdar. 
 
Infektionsdynamik 
I den fjärde studien beskrivs infektionsdynamiken under en tre års period. 
Här ingick besättningarna från Jämtland och Västerbotten i norr samt 
Halland och Gotland i söder. I de två södra landskapen var det kontinuerligt 
hög andel gårdar som var antikroppspositiva (85-100%), medan det i norr 
varierade; för BCV 38-80% och BRSV 0-80%. Bland de jämtländska 
besättningarna sjönk förekomsten av antikroppar mot BRSV under 
studieperioden och Jämtland bedömdes vara fria från cirkulerande BRSV vid 
sista provtagningen våren 2009. Detta indikerar att det går att få ett område 
fritt från BRSV.  
Av de besättningar som var antikroppsnegativa i tankmjölken vid första 
provtagningen hösten 2006, alternativt blev antikroppsnegativa under 
studieperioden (5 för BCV och 8 för BRSV), förblev alla negativa utom en 
besättning i Västerbotten som serokonverterade mot BCV. Dessa besättningar 
återfanns i de norra områdena utom en gård i Halland som var negativ mot 
BCV.    46
 
8.3  Möjlighet till kontroll 
Baserat på resultaten i denna doktorsavhandling tror vi att det på ett 
kostnadseffektivt och praktiskt genomförbart sätt, genom ett ökat 
smittskydd, går organisera ett frivilligt kontrollprogram mot BCV och BRSV. 
Norra Sverige är lämpligt för en start av ett sådant program på grund av det 
fördelaktiga smittoläget. Övervakningen kan till en början ske genom analys 
av antikroppar i samlingsprover av mjölk från förstakalvare för att sedan 
(förutsatt att förekomsten minskar) gradvis övergå till tankmjölksprover. Vi 
tror att vetskapen om besättningens antikroppsstatus tillsammans med 
information om infektionerna kommer leda till ett ökat intresse för 
smittskydd och en ökad mottaglighet för nya rutiner hos alla aktörer. För att 
få ut nya rekommendationer baserat på forskningsstudier måste det finnas en 
strategi för kommunikation mellan forskare och djurägare/veterinärer m.fl. 
Därför bör djurägare och personer verksamma i fältet vara med och utforma 
de nya rutinerna.  
  För att få uthållig djurhållning måste smittskyddet skärpas i svenska 
besättningar. Trots att smittskyddsrutiner har rekommenderats i många år är 
de fortfarande otillräckliga i många besättningar enligt en nyligen publicerad 
studie (Nöremark et al., 2010). Ett stärkt smittskydd skulle inte bara 
förhindra spridningen av BCV och BRSV utan också minska spridningen av 
andra smittämnen. En minskad frekvens av BCV och BRSV infektioner skulle 
förbättra djurvälfärden, vara ekonomiskt viktigt för djurägaren och minska 
användningen av antibiotika.  
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